CA2905180C - Temperature shift for high yield expression of polypeptides in yeast and other transformed cells - Google Patents

Temperature shift for high yield expression of polypeptides in yeast and other transformed cells Download PDF

Info

Publication number
CA2905180C
CA2905180C CA2905180A CA2905180A CA2905180C CA 2905180 C CA2905180 C CA 2905180C CA 2905180 A CA2905180 A CA 2905180A CA 2905180 A CA2905180 A CA 2905180A CA 2905180 C CA2905180 C CA 2905180C
Authority
CA
Canada
Prior art keywords
antibody
culture
temperature
yeast
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2905180A
Other languages
English (en)
French (fr)
Other versions
CA2905180A1 (en
Inventor
Gary LESNICKI
Patricia Dianne Mcneill
Franz Hartner
Mark Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of CA2905180A1 publication Critical patent/CA2905180A1/en
Application granted granted Critical
Publication of CA2905180C publication Critical patent/CA2905180C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • C07K16/248IL-6
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Analytical Chemistry (AREA)
CA2905180A 2013-03-15 2014-03-17 Temperature shift for high yield expression of polypeptides in yeast and other transformed cells Active CA2905180C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361790613P 2013-03-15 2013-03-15
US201361791471P 2013-03-15 2013-03-15
US61/790,613 2013-03-15
US61/791,471 2013-03-15
PCT/US2014/030453 WO2014145650A1 (en) 2013-03-15 2014-03-17 Temperature shift for high yield expression of polypeptides in yeast and other transformed cells

Publications (2)

Publication Number Publication Date
CA2905180A1 CA2905180A1 (en) 2014-09-18
CA2905180C true CA2905180C (en) 2023-03-07

Family

ID=51538058

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2905180A Active CA2905180C (en) 2013-03-15 2014-03-17 Temperature shift for high yield expression of polypeptides in yeast and other transformed cells

Country Status (15)

Country Link
US (2) US10138294B2 (https=)
EP (2) EP2971037B1 (https=)
JP (1) JP6412552B2 (https=)
KR (1) KR102202477B1 (https=)
CN (1) CN105121652B (https=)
AU (1) AU2014232813B2 (https=)
CA (1) CA2905180C (https=)
DK (1) DK2971037T3 (https=)
ES (2) ES3057435T3 (https=)
IL (1) IL241176B (https=)
MX (2) MX366647B (https=)
SG (1) SG11201506034TA (https=)
TW (1) TWI636136B (https=)
WO (1) WO2014145650A1 (https=)
ZA (1) ZA201505483B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10202630B2 (en) * 2013-03-15 2019-02-12 Alderbio Holdings Llc Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
PE20161439A1 (es) 2014-03-21 2017-01-26 Teva Pharmaceuticals Int Gmbh Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
JP2018501814A (ja) 2014-11-11 2018-01-25 クララ フーズ カンパニー 卵白タンパク質産生のための方法および組成物
JP2017045865A (ja) 2015-08-26 2017-03-02 ルネサスエレクトロニクス株式会社 半導体装置およびその製造方法
CN106191181B (zh) * 2016-07-22 2019-12-13 江苏江山聚源生物技术有限公司 一种毕赤酵母表达重组蛋白的发酵工艺
WO2018055574A1 (en) 2016-09-23 2018-03-29 Teva Pharmaceuticals International Gmbh Treating refractory migraine
EP3592800A4 (en) 2017-03-10 2021-01-06 Bolt Threads, Inc. COMPOSITIONS AND METHODS OF PRODUCING HIGHLY SECRETED YIELD OF RECOMBINANT PROTEIN
KR20250121449A (ko) 2017-03-10 2025-08-12 볼트 쓰레즈, 인크. 재조합 단백질을 고분비 수율로 생산하기 위한 조성물 및 방법
IL277352B2 (en) * 2018-03-16 2025-08-01 Genzyme Corp Methods for improving cell viability in a production bioreactor
US10221403B1 (en) * 2018-04-25 2019-03-05 Life Rainbow Biotech Co., Ltd. Method of preparing zearalenone hydrolase
CN108546637A (zh) * 2018-05-23 2018-09-18 华东理工大学 重组毕赤酵母表达葡萄糖氧化酶发酵装置以及发酵培养方法
MX2021000053A (es) * 2018-07-12 2021-03-25 Amyris Inc Metodos para controlar velocidades de alimentacion de la fermentacion.
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
BR112022000545A2 (pt) 2019-07-11 2022-04-05 Clara Foods Co Composições de proteína e produtos de consumo destas
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
FI4055177T3 (fi) * 2019-11-08 2024-10-31 Danisco Us Inc Parantuneen proteiinituottavuuden fenotyyppejä käsittäviä sienikantoja ja menetelmiä niitä varten
WO2021146233A1 (en) 2020-01-14 2021-07-22 Basf Se Method for producing recombinant protein in yeast cells
US20250207158A1 (en) * 2022-03-24 2025-06-26 Versalis S.P.A. Fermentation process for the production of lipids from oleaginous yeasts
EP4594342A2 (en) * 2022-09-29 2025-08-06 Antheia, Inc. Methods of improving production of morphinan alkaloids and derivatives

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4818700A (en) 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US4812405A (en) 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
WO1994021293A1 (en) 1993-03-19 1994-09-29 Duke University Method of treatment of tumors with an antibody binding to tenascin
ES2251723T3 (es) 1994-08-12 2006-05-01 Immunomedics, Inc. Inmunoconjugados y anticuerpos humanizados especificos para linfoma de celulas b y celulas de leucemia.
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US6730499B1 (en) 1998-07-03 2004-05-04 Research Corporation Technologies, Inc. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1
US6258559B1 (en) 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
US6221630B1 (en) 1999-03-24 2001-04-24 The Penn State Research Foundation High copy number recombinant expression construct for regulated high-level production of polypeptides in yeast
PT1678314E (pt) 2003-10-22 2012-11-27 Keck Graduate Inst Métodos de síntese de polipéptidos heteromultiméricos em levedura utilizando uma estratégia de conjugação haplóide
DK2021463T3 (en) 2006-05-19 2017-01-16 Alder Biopharmaceuticals Inc Culture method to obtain a cloned population of antigen-specific B cells
HUE032563T2 (en) 2007-05-21 2017-09-28 Alderbio Holdings Llc Antibodies to IL-6 and their use
KR20170036814A (ko) 2007-05-21 2017-04-03 앨더바이오 홀딩스 엘엘씨 신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
US20090269832A1 (en) 2007-11-05 2009-10-29 Modular Genetics, Inc. Growth of Microorganisms in Media Containing Crude Glycerol
US8501449B2 (en) 2007-12-04 2013-08-06 Proteon Therapeutics, Inc. Recombinant elastase proteins and methods of manufacturing and use thereof
US8609416B2 (en) 2009-12-18 2013-12-17 Ventria Bioscience Methods and compositions comprising heat shock proteins
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US10150968B2 (en) 2011-08-19 2018-12-11 Alderbio Holdings Llc Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
EP2744903B1 (en) 2011-08-19 2018-10-10 AlderBio Holdings LLC Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as a antibodies in transformed microbes such as pichia pastoris
US10202630B2 (en) * 2013-03-15 2019-02-12 Alderbio Holdings Llc Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
US10189892B2 (en) * 2013-03-15 2019-01-29 Alderbio Holdings Llc Fermentation process for antibody production

Also Published As

Publication number Publication date
TWI636136B (zh) 2018-09-21
TW201512401A (zh) 2015-04-01
WO2014145650A1 (en) 2014-09-18
EP3597664A2 (en) 2020-01-22
ES3057435T3 (en) 2026-03-02
EP2971037A1 (en) 2016-01-20
US10138294B2 (en) 2018-11-27
US11447540B2 (en) 2022-09-20
US20160039911A1 (en) 2016-02-11
MX366647B (es) 2019-07-17
EP3597664C0 (en) 2025-11-26
EP2971037B1 (en) 2019-07-10
JP2016516412A (ja) 2016-06-09
SG11201506034TA (en) 2015-09-29
EP3597664B1 (en) 2025-11-26
IL241176A0 (en) 2015-11-30
MX2015011968A (es) 2017-01-06
CA2905180A1 (en) 2014-09-18
MX384491B (es) 2025-03-14
US20190119360A1 (en) 2019-04-25
AU2014232813B2 (en) 2017-12-07
AU2014232813A1 (en) 2015-09-03
CN105121652A (zh) 2015-12-02
NZ711400A (en) 2021-05-28
DK2971037T3 (da) 2019-10-14
ES2749751T3 (es) 2020-03-23
EP2971037A4 (en) 2016-07-20
EP3597664A3 (en) 2020-03-11
MX2019008417A (es) 2019-09-13
KR20150140678A (ko) 2015-12-16
KR102202477B1 (ko) 2021-01-13
ZA201505483B (en) 2022-08-31
CN105121652B (zh) 2020-07-28
IL241176B (en) 2020-05-31
JP6412552B2 (ja) 2018-10-24

Similar Documents

Publication Publication Date Title
US11447540B2 (en) Pichia pastoris yeast cultures comprising reduced antibody-associated variants
US11225667B2 (en) Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
AU2012299035B2 (en) Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US12077794B2 (en) Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
MX2013013532A (es) Produccion de alta pureza de proteinas multi-subunitarias tales como anticuerpos en microbios transformados tal como pichia pastoris.
HK40020901B (en) Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
HK40020901A (en) Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
NZ711400B2 (en) Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
NZ621199B2 (en) Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
NZ721102B2 (en) Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190315

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250121

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250121

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250121

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260105

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260105